SUBSCRIBE
SUBSCRIBE
News   Drug Development

New Data Shows Promise of German Merck KGaA’s MS Drug

September 11, 2009 | 
1 min read
Bookmark and Share

Reuters -- A new analysis of data from a clinical trial of Merck KGaA's oral drug cladribine has underscored its potential as a treatment for multiple sclerosis, researchers said on Friday.
Clinical research Phase 3
MORE ON THIS TOPIC
Electricity saving, ecology awareness or reduce electric cost and expense concept, man pulling electric cord to unplug to save money or for ecology power.
Lung cancer
AstraZeneca pulls plug on late-stage lung cancer trial, extending losing streak
August 17, 2026
 · 
2 min read
 · 
Tristan Manalac
Modern collage with two hands tie a knot in a rope. Tug of war. Two hands pull on a rope with a knot in the middle. Strong connections concept. Successful business deal. Newspaper elements
IgA nephropathy
Vera’s newly approved IgA nephropathy drug supports kidney function, like Otsuka’s Voyxact
August 17, 2026
 · 
2 min read
 · 
Tristan Manalac
Doctor holding syringe on Italy flag background. Medical professional holding syringe with Italian flag in the background
Insights
Italian biotech gains momentum as VC funding, tech transfer environment improve
August 17, 2026
 · 
3 min read
 · 
Jennifer C. Smith-Parker
Red rocket with clouds rising up as metaphor for business and financial growth, Success and financial developing, Business growth concept, paper cut style.
Drug Development
Capricor soars on potential FDA review extension, filing amendments
August 14, 2026
 · 
4 min read
 · 
Gabrielle Masson